The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


VAQTA Paediatric 25 U/0.5 mL, suspension for injection in a prefilled syringe. Hepatitis A vaccine, inactivated, adsorbed. For children and adolescents

25 U/0.5 millilitre(s) Suspension for injection in pre-filled syringe

Merck Sharp & Dohme Ireland (Human Health) LimitedPA1286/056/001

Main Information

Trade NameVAQTA Paediatric 25 U/0.5 mL, suspension for injection in a prefilled syringe. Hepatitis A vaccine, inactivated, adsorbed. For children and adolescents
Active SubstancesHepatitis a vaccine
Strength25 U/0.5 millilitre(s)
Dosage FormSuspension for injection in pre-filled syringe
Licence HolderMerck Sharp & Dohme Ireland (Human Health) Limited
Licence NumberPA1286/056/001

Group Information

ATC CodeJ07BC Hepatitis vaccines
J07BC02 hepatitis A, inactivated, whole virus

Status

Authorised/WithdrawnAuthorised
Licence Issued13/12/1996
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches of vaccine marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC as amended.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back